115 related articles for article (PubMed ID: 16980103)
21. Helicobacter pylori and reflux disease.
Hayee B; Harris A
Lancet; 2001 Nov; 358(9294):1730-1. PubMed ID: 11728581
[No Abstract] [Full Text] [Related]
22. Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: a liaison dangereuse or an innocent interplay?
Parente FR; Bargiggia SA; Anderloni A
Scand J Gastroenterol; 2006 Oct; 41(10):1121-5. PubMed ID: 16990195
[No Abstract] [Full Text] [Related]
23. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
[TBL] [Abstract][Full Text] [Related]
25. Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett's--what is the interplay?
Sharma P
Gut; 2005 Jun; 54(6):739-40. PubMed ID: 15888772
[No Abstract] [Full Text] [Related]
26. Gastro-oesophageal reflux and Helicobacter pylori.
Pace F; Bianchi Porro G
Dig Liver Dis; 2000 Dec; 32 Suppl 3():S202-6. PubMed ID: 11245296
[No Abstract] [Full Text] [Related]
27. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?
Labenz J; Malfertheiner P
Gut; 1997 Sep; 41(3):277-80. PubMed ID: 9378377
[No Abstract] [Full Text] [Related]
28. H. pylori-infected gastroesophageal reflux disease patients harbor less virulent strains.
Fallone CA; Barkun AN
Am J Gastroenterol; 2002 Apr; 97(4):1065. PubMed ID: 12003394
[No Abstract] [Full Text] [Related]
29. The impact of body mass index and Helicobacter pylori infection on gastro-oesophageal reflux symptoms: a population-based study in Northern Norway.
Breckan RK; Paulssen EJ; Asfeldt AM; Mortensen L; Straume B; Florholmen J
Scand J Gastroenterol; 2009; 44(9):1060-6. PubMed ID: 19593688
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of gastroesophageal reflux: should Helicobacter pylori infection be taken into account?].
De Korwin JD
Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S121-9. PubMed ID: 10078440
[No Abstract] [Full Text] [Related]
31. Helicobacter pylori and gastro-oesophageal reflux disease: important data were not presented.
Beales IL
BMJ; 2004 Aug; 329(7462):402. PubMed ID: 15310619
[No Abstract] [Full Text] [Related]
32. Review article: trials on reflux disease -- the role of acid secretion and inhibition.
Sonnenberg A
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():2-8; discussion 38-9. PubMed ID: 15456457
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter pylori and gastro-oesophageal reflux disease: information underlying pathology is not given.
Cammarota G; Gasbarrini GB
BMJ; 2004 Aug; 329(7462):402. PubMed ID: 15310618
[No Abstract] [Full Text] [Related]
34. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
Lundell L
Eur J Gastroenterol Hepatol; 2001 May; 13 Suppl 1():S23-7. PubMed ID: 11430505
[TBL] [Abstract][Full Text] [Related]
35. Definitions and classification of dyspepsia: pH, Helicobacter pylori, non-steroidal anti-inflammatory drugs--should we include gastro-oesophageal reflux disease?
Bazzoli F
Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():15-6, 21-4. PubMed ID: 15755270
[No Abstract] [Full Text] [Related]
36. Gastro-oesophageal reflux disease.
Fox M; Forgacs I
BMJ; 2006 Jan; 332(7533):88-93. PubMed ID: 16410582
[No Abstract] [Full Text] [Related]
37. Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring.
Zentilin P; Mastracci L; Dulbecco P; Gambaro C; Bilardi C; Ceppa P; Spaggiari P; Iiritano E; Mansi C; Vigneri S; Fiocca R; Savarino V
Aliment Pharmacol Ther; 2004 Jun; 19(12):1285-92. PubMed ID: 15191510
[TBL] [Abstract][Full Text] [Related]
38. Gastro-oesophageal reflux disease: current etiologic, pathogenic and diagnostic aspects.
Sobrino Faya M; Domínguez Muñoz JE
Rev Esp Enferm Dig; 2001 Feb; 93(2):115-24. PubMed ID: 11471224
[No Abstract] [Full Text] [Related]
39. [Gastroesophageal reflux disease (GERD). Barrett esophagus].
Kato M
Nihon Rinsho; 2009 Dec; 67(12):2357-65. PubMed ID: 19999125
[TBL] [Abstract][Full Text] [Related]
40. [Helicobacter pylori and gastro-esophageal reflux disease: clinical considerations].
Berrutti M; Fagoonee S; Astegiano M; Pellicano R; Rizzetto M
Minerva Gastroenterol Dietol; 2007 Jun; 53(2):153-6. PubMed ID: 17557043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
